Oncological Outcomes of Sub-Lobar Resection Versus Lobectomy for Stage I Non-Small Cell Lung Cancer.

Maurish FatimaAyesha SeharZaofashan ZaheerMuhammad Hammad KhanObaid Ur RehmanSyeda Fatima AbidUnaiza AhmadAhmed BajwaHuzaifa Ahmad CheemaHannan A MaqsoodRussell Seth MartinsSyed Asghar Naqi

Published in: The Journal of surgical research (2024)

The patients with stage I NSCLC who underwent sub-lobar resection showed a significantly worse DFS and OS in the "compromised group." However, there was no overall significant difference in OS, DFS, or mortality in the sub-lobar resection group as compared to lobectomy.

Keyphrases

small cell lung cancer
cardiovascular events
type diabetes
rectal cancer
risk factors
metabolic syndrome
minimally invasive
tyrosine kinase